Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
10/26/2006 | DE102005020105A1 New thiazolidinone compounds are polo-like kinase inhibitors, useful for the preparation of medicament to treat e.g. cancer, autoimmune disease, cardiovascular disease stenosis and infection disease |
10/26/2006 | DE102005020104A1 New thiazolidinone compounds are polo-like kinase inhibitors, useful for the preparation of medicament to treat e.g. cancer, autoimmune disease, cardiovascular disease stenosis and infection disease |
10/26/2006 | DE102005019094A1 New aza-heterocyclic compounds are tyrosine kinase inhibitor useful to prevent and/or treat cancer, tumor growth, tumor angiogenesis, arteriosclerosis, diabetic retinopathy and inflammation diseases |
10/26/2006 | CA2605059A1 Oxindole compounds and their uses as therapeutic agents |
10/26/2006 | CA2604912A1 Use of tafi inhibitors for enhanced myocardial reperfusion and facilitated pci |
10/26/2006 | CA2604295A1 Roflumilast for the treatment of pulmonary hypertension |
10/25/2006 | EP1714979A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
10/25/2006 | EP1714970A1 Use of inhibitors of RNAse A-family enzymes for stabilizing oligonucleotides having RNA interfering activity |
10/25/2006 | EP1714963A1 Process for the Preparation of Valsartan and its Intermediates |
10/25/2006 | EP1714961A1 Indazole compound and pharmaceutical use thereof |
10/25/2006 | EP1714661A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity |
10/25/2006 | EP1714659A1 A biological active blood serum for the treatment of stroke |
10/25/2006 | EP1714654A1 Drug for inhibiting vascular intimal hyperplasia |
10/25/2006 | EP1714652A2 Use of thiazolidinediones to prevent or delay onset of niddm |
10/25/2006 | EP1714651A1 Use of angiotensin II receptor antagonists for treating acute myocardial infarction |
10/25/2006 | EP1714648A1 Combination drug |
10/25/2006 | EP1713797A1 1-ISOPROPYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE DERIVATIVES HAVING 5-HT sb 4 /sb RECEPTOR AGONISTIC ACTIVITY |
10/25/2006 | EP1713771A1 New crystalline form of perindopril |
10/25/2006 | EP1713541A1 Use of alkaline phosphatase for the detoxification of lps |
10/25/2006 | EP1713480A2 The use of quaternary pyridinium salts as vasoprotective agents |
10/25/2006 | EP1713469A1 Hypocholesterolemic compositions comprising a statin and an antiflatulent agent |
10/25/2006 | EP1713467A1 Compositions and methods of use of a-type procyanidins |
10/25/2006 | EP1713462A1 A method of modulating pro-inflammatory and inflammatory activity mediated by c-reactive protein |
10/25/2006 | EP1713452A2 Sustained release pharmaceutical composition of indapamide |
10/25/2006 | EP1517909B1 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
10/25/2006 | EP1509498B1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same |
10/25/2006 | EP1490030B1 Nanoparticulate compositions of angiogenesis inhibitors |
10/25/2006 | EP1458718B1 Quinolinones as prostaglandin receptor ligands |
10/25/2006 | EP1430053B1 AZAOXOINDOLE DERIVATIVES AS Trk PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND CHRONIC PAIN |
10/25/2006 | EP1392689B1 Tri- and tetraaza-acenaphthylen derivatives as crf receptor antagonists |
10/25/2006 | EP1331938B1 Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome |
10/25/2006 | EP1313476B1 Sgk3 used as diagnostic and therapeutic target |
10/25/2006 | EP1153302B1 Diagnostics and therapeutics for macular degeneration |
10/25/2006 | EP1097167B1 Neurotrophic growth factor |
10/25/2006 | EP1079811B1 Biodegradable sustained-release alginate gels |
10/25/2006 | EP0828849B1 High-affinity oligonucleotide ligands to pdgf |
10/25/2006 | EP0827408B1 Method of administration of igf-i |
10/25/2006 | CN1852979A Modulation of eIF4E expression |
10/25/2006 | CN1852749A Use of dapsone as a neuroprotector in cerebral infarction |
10/25/2006 | CN1852748A Azepine derivatives as pharmaceutical agents |
10/25/2006 | CN1852744A Endoluminal prosthesis comprising a therapeutic agent |
10/25/2006 | CN1852731A Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
10/25/2006 | CN1852726A Oral compositions for the treatment of cellulite |
10/25/2006 | CN1852710A Pyrazolines as PAR-1 antagonists for treatment of cardiovascular diseases |
10/25/2006 | CN1852709A Macrophage activation inhibitor |
10/25/2006 | CN1850847A Method for preparing periplogenin |
10/25/2006 | CN1850838A Scutellarin raw material drug preparing method |
10/25/2006 | CN1850836A Celosia argentea suponin compound and its pharmaceutical use |
10/25/2006 | CN1850820A Coumarin derivatives, and their preparing method and use as alpha, receptor agonist |
10/25/2006 | CN1850801A Method for preparing amlodipine benzenesulfonate |
10/25/2006 | CN1850764A 6,7-dehydroxyleanone in salvia farinacea root with platelet aggregation inhibition |
10/25/2006 | CN1850261A Medicine composition for treating apoplexy and apoplexy involving both collateral and meridian and preparing method |
10/25/2006 | CN1850254A Chinese medicine preparation for treating deficiency of qi and blood and preparing method |
10/25/2006 | CN1850212A Valerianoil liquid hard capsule, and its preparing method |
10/25/2006 | CN1850207A Fructus-sophorae Radix et Rhizoma sanguisorbae preparation and new preparing method |
10/25/2006 | CN1850192A Medicine composition for treating cerebral embolism sequela and rheumatoid arthritis and preparing method |
10/25/2006 | CN1850186A Medicine for treating cerebral hemorrhage and preparing method |
10/25/2006 | CN1850185A Yixinshu Injecta for retaliation of Qi and pulse and promotion of blood circulation and removing of blood stasis, and preparing method therefor |
10/25/2006 | CN1850160A Qidantongmai Tablet, and its preparing process |
10/25/2006 | CN1850153A Method for preparing Radix puerariae and cenlian decoction |
10/25/2006 | CN1850139A Preparing method for oral instant-dissolving tablet for calming brain |
10/25/2006 | CN1850137A Method for preparing Radix-Acanthopanacis-leaf extract for treating cardiovascular and cerebrovascalar diseases |
10/25/2006 | CN1850131A Medicine composition for treating cardiovascular and cerebrovascular diseases |
10/25/2006 | CN1850129A Medicine preparation for preventing and treating heart brain and kidney blood vessel diseases |
10/25/2006 | CN1850128A Pine pollen composition with beauty nourish function to face, intensifying immunity of body |
10/25/2006 | CN1850093A Stibene-glucoside oral liquid and its production method |
10/25/2006 | CN1850081A Use of 5-(3-aminobenzene)methyl nicotinate and its ahalogue as PI3K enzyme inhibitor |
10/25/2006 | CN1850073A Medicinal composition containing ampicillin and its preparing method |
10/25/2006 | CN1850069A Method for preparing Tengchasu dispersibletablet and its use |
10/25/2006 | CN1850068A Medicinal composition for treating cardio-cerebral-vascular disease and its preparing method |
10/25/2006 | CN1850057A Method for preparing insoluble drug single-tablet-core single-chamber osmotic pump sustained-release preparations and its product |
10/25/2006 | CN1850055A Flunarizine hydrochloride lyophilized agent for injection and its preparing method |
10/25/2006 | CN1281743C Preparation method of earthworm kinase dry powder |
10/25/2006 | CN1281608C New azo-indolyl derivatives |
10/25/2006 | CN1281604C Substituted pyrazole compounds |
10/25/2006 | CN1281598C Compounds and methods for modulation of estrogen receptors |
10/25/2006 | CN1281597C New compounds, which are potent inhibitors of Na<+>/Ca<2+> exchange mechanism and are useful in the treatment of arrhythmias |
10/25/2006 | CN1281590C Hexavalent amino amidate derivative with function of inhibiting blood vessel growth activity |
10/25/2006 | CN1281588C Novel intermediate for preparation of pyrazolopyrimidinones |
10/25/2006 | CN1281585C Cyclic diamine compounds having fused-ring groups |
10/25/2006 | CN1281278C Gene-carrying micro-bublle of target transfergene, its preparation method and use |
10/25/2006 | CN1281268C Chinese medicinal composition for supplementing Qi, nourishing heart and calming mind and its preparation and identification method |
10/25/2006 | CN1281261C Capsule for treating hypertension and coronary disease and its preparing method |
10/25/2006 | CN1281240C Medicinal composition for preventing and treating cardiovascular heart disease and its preparation |
10/25/2006 | CN1281231C External use medicinal composition for softening and dredging pyramis arteriosclerosis and its preparation method |
10/25/2006 | CN1281227C Bunao Yishen Runchang Capsule for replenishing brain and kidney and moistening intestines |
10/25/2006 | CN1281223C Myocarditis treating medicine and its preparing process |
10/25/2006 | CN1281219C Medicine for treating piles and its preparation method |
10/25/2006 | CN1281217C Use of activated carbon in oral medicinal preparation for hyperthyroidism |
10/25/2006 | CN1281215C The second purpose of Siberian solomonseal rhizome polysaccharide |
10/25/2006 | CN1281214C Process for preparing ginkgo leaf extract powder injection |
10/25/2006 | CN1281213C Process method for preparing sodium chloride injection of ginkgo leaf extract |
10/25/2006 | CN1281212C General saponin of stem and leaf of American ginseng in Application of preparing medication for treating mycoarditis |
10/25/2006 | CN1281206C Orally disintegrating tablet of 'Xinxuekang' and manufacture method of the same |
10/24/2006 | US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents |
10/24/2006 | US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
10/24/2006 | US7126008 Carvedilol |
10/24/2006 | US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS) |
10/24/2006 | US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms |
10/24/2006 | US7125906 Indole derivatives having anti-angiogenetic activity |